A DESIGN FOR PHASE-II TESTING OF ANTICANCER AGENTS WITHIN A PHASE-III CLINICAL-TRIAL

被引：18
|
作者：
SCHAID, DJ [1 ]
INGLE, JN [1 ]
WIEAND, S [1 ]
AHMANN, DL [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,DIV MED ONCOL,ROCHESTER,MN 55905
来源：
CONTROLLED CLINICAL TRIALS | 1988年 / 9卷 / 02期
关键词：
D O I：
10.1016/0197-2456(88)90032-3
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：107 / 118
页数：12
相关论文
共 50 条
  • [41] RESULTS OF THE INVITRO FERTILIZATION PROGRAM AT TYGERBERG-HOSPITAL, PHASE-II AND PHASE-III
    KRUGER, TF
    VANDERMERWE, JP
    STANDER, FSH
    MENKVELD, R
    VANDENHEEVER, AD
    KOPPER, K
    ODENDAAL, HJ
    VANZYL, JA
    DEVILLIERS, JN
    SOUTH AFRICAN MEDICAL JOURNAL, 1986, 69 (05): : 297 - 300
  • [42] MECHANICAL CHARACTERISTICS OF PHASE-II AND PHASE-III OF THE INTERDIGESTIVE MIGRATING MOTOR COMPLEX IN DOGS
    SCHEMANN, M
    EHRLEIN, HJ
    GASTROENTEROLOGY, 1986, 91 (01) : 117 - 123
  • [43] COMPARATIVE PHASE-III CLINICAL-TRIAL OF LATANOPROST AND TIMOLOL IN PATIENTS WITH ELEVATED INTRAOCULAR-PRESSURE
    ALM, A
    PROSTAGLANDINS AND RELATED COMPOUNDS: NINTH INTERNATIONAL CONFERENCE, FLORENCE, ITALY, 1995, 23 : 527 - 532
  • [44] PERFLUBRON AS AN ORAL CONTRAST AGENT FOR MR-IMAGING - RESULTS OF A PHASE-III CLINICAL-TRIAL
    MATTREY, RF
    TRAMBERT, MA
    BROWN, JJ
    YOUNG, SW
    BRUNETON, JN
    WESBEY, GE
    BALSARA, ZN
    RADIOLOGY, 1994, 191 (03) : 841 - 848
  • [45] POSITIVE BOWEL CONTRAST AGENT FOR MR-IMAGING OF THE ABDOMEN - PHASE-II AND PHASE-III CLINICAL-TRIALS
    PATTEN, RM
    LO, SK
    PHILLIPS, JJ
    BOWMAN, SC
    GLAZER, GM
    WALL, SD
    BOVA, JG
    HARRIS, RD
    WHEAT, RL
    JOHNSON, CD
    KRESSEL, HY
    STILLMAN, AE
    HALVORSEN, RA
    MOSS, AA
    RADIOLOGY, 1993, 189 (01) : 277 - 283
  • [46] IMPROVEMENT OF PHASE-III PSYCHOTROPIC-DRUG TRIALS BY INTENSIVE PHASE-II WORK - REPLY
    KLEIN, DF
    NEUROPSYCHOPHARMACOLOGY, 1991, 4 (04) : 269 - 271
  • [47] IMPROVEMENT OF PHASE-III PSYCHOTROPIC-DRUG TRIALS BY INTENSIVE PHASE-II WORK - COMMENT
    LASAGNA, L
    NEUROPSYCHOPHARMACOLOGY, 1991, 4 (04) : 263 - 264
  • [48] NUCLEATION KINETICS OF POLYMORPHIC TRANSITION FROM PHASE-II TO PHASE-III OF HEXACHLOROETHANE - METASTABILITY UNSTABILITY
    KOGA, Y
    PHYSICA B & C, 1987, 146 (03): : 408 - 415
  • [49] EXPERIMENTAL DESIGN AND STATISTICS IN PHASE-II AND III
    UBERLA, K
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1975, 25 (NA7): : 1203 - 1207
  • [50] A PHASE-II CLINICAL-TRIAL OF 4'-EPI-DOXORUBICIN IN ADVANCED SOLID TUMORS
    MARTONI, A
    GIOVANNINI, M
    TOMASI, L
    CAMAGGI, CM
    BELLANOVA, B
    MONETTI, N
    ROSSINI, G
    TARQUINII, M
    MARTINI, A
    PANNUTI, F
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 12 (03) : 179 - 182
12345